Feb 18 (Reuters) - Galectin Therapeutics Inc GALT.O:
GALECTIN THERAPEUTICS INC - REPORTS SIGNIFICANT REDUCTION IN NEW VARICES WITH BELAPECTIN
GALECTIN THERAPEUTICS INC - NAVIGATE TRIAL SHOWS 68.1% REDUCTION IN NEW VARICES WITH BELAPECTIN
GALECTIN THERAPEUTICS INC - ADDITIONAL DATA OF NAVIGATE TRIAL EXPECTED BY END OF Q1 2025
Source text: [ID:n0001140361-25-004971]
Further company coverage: GALT.O